Among the most promising innovations in the healthy aging space is Cerenity™, a clinically studied probiotic formulation developed by Lallemand Health Solutions
Products & Services
Immuse by Lallemand
Lallemand
Earlier this year, Lallemand Health Solutions and Kirin Holdings Company, Limited announced a strategic partnership to expand the visibility of IMMUSE®, a clinically researched lactic acid bacteria developed by Kirin Holdings Company, Limited. IMMUSE® is a heat-inactivated Lactococcus lactis strain Plasma, backed by 15 clinical trials demonstrating its efficacy in supporting immune health through a distinctive mode of action.
Prenatis by Lallemand
Lallemand
Year after year, important R&D efforts are invested to bring forward innovative health solutions for women. Discover the results of a new clinical study exploring the benefits of probiotics on healthy women during pregnancy. Prenatis® helps to maintain a healthy pregnancy and contribute to the establishment of a healthy infant microbiome during the first months of life.
People
Description
Aging is intricately linked to changes in gut health that may significantly influence skeletal muscle mass and function, highlighting the Gut-Muscle Axis, a dynamic interplay where the gut microbiota impacts muscle health. Discover Cerenity™, a powerful blend of three Lallemand Health Solutions' flagship probiotic strains, recently studied to support the gut-muscle axis and demonstrating beneficial effects on mobility, strength, and quality of life in older adults.
